These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2265771

  • 1. Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.
    Kuriyama S, Ohuchi T, Yoshimura N, Honda Y, Hiraoka M, Abe M.
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):552-5. PubMed ID: 2265771
    [Abstract] [Full Text] [Related]

  • 2. Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.
    Steinhorst UH, Chen EP, Hatchell DL, Samsa GP, Saloupis PT, Westendorf J, Machemer R.
    Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1753-60. PubMed ID: 8473115
    [Abstract] [Full Text] [Related]

  • 3. N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina.
    Steinhorst UH, Chen EP, Machemer R, Hatchell DL.
    Exp Eye Res; 1993 Apr; 56(4):489-95. PubMed ID: 8500561
    [Abstract] [Full Text] [Related]

  • 4. Irradiation pretreatment before fibroblast implantation in experimental PVR.
    Velikay M, Stolba U, Wedrich A, Datlinger P, Binder S, Handl-Zeller L.
    Int Ophthalmol; 1993 Aug; 17(4):191-3. PubMed ID: 8112965
    [Abstract] [Full Text] [Related]

  • 5. Hyperthermia reduces the occurrence of proliferative vitreoretinopathy in a rabbit model.
    Yoshimura N, Kuriyama S, Ohuchi T, Takemura M, Honda Y, Hiraoka M.
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):404-9. PubMed ID: 1740372
    [Abstract] [Full Text] [Related]

  • 6. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.
    Khawly JA, Saloupis P, Hatchell DL, Machemer R.
    Graefes Arch Clin Exp Ophthalmol; 1991 Feb; 229(5):464-7. PubMed ID: 1937080
    [Abstract] [Full Text] [Related]

  • 7. Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy.
    Yang CM, Olsen KR, Hernandez E, Cousins SW.
    Graefes Arch Clin Exp Ophthalmol; 1992 Feb; 230(1):66-71. PubMed ID: 1547971
    [Abstract] [Full Text] [Related]

  • 8. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy.
    Nakagawa M, Refojo MF, Marin JF, Doi M, Tolentino FI.
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of experimental proliferative vitreoretinopathy in rabbits].
    Kuriyama S, Ohuchi T, Okada M, Yamakawa R, Yoshimura N, Honda Y.
    Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):792-8. PubMed ID: 2248164
    [Abstract] [Full Text] [Related]

  • 10. Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy.
    Moritera T, Ogura Y, Yoshimura N, Honda Y, Wada R, Hyon SH, Ikada Y.
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3125-30. PubMed ID: 1399416
    [Abstract] [Full Text] [Related]

  • 11. Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment.
    Chandler DB, Hida T, Sheta S, Proia AD, Machemer R.
    Graefes Arch Clin Exp Ophthalmol; 1987 Oct; 225(4):259-65. PubMed ID: 3653718
    [Abstract] [Full Text] [Related]

  • 12. Experimental perforating injury with high energy electrons to inhibit intraocular proliferation.
    Velikay M, Binder S, Stolba U, Wedrich A, Datlinger P, Handl-Zeller L.
    Acta Ophthalmol (Copenh); 1994 Jun; 72(3):337-40. PubMed ID: 7976264
    [Abstract] [Full Text] [Related]

  • 13. The lack of an effect of intraocular steroids on irradiated fibroblasts in experimental proliferative vitreoretinopathy.
    Chandler DB, Hida T, Rozakis G, Forbes VS, Machemer R.
    Graefes Arch Clin Exp Ophthalmol; 1992 Jun; 230(2):188-91. PubMed ID: 1577303
    [Abstract] [Full Text] [Related]

  • 14. Taxol treatment of experimental proliferative vitreoretinopathy.
    Daniels SA, Coonley KG, Yoshizumi MO.
    Graefes Arch Clin Exp Ophthalmol; 1990 Jun; 228(6):513-6. PubMed ID: 1979953
    [Abstract] [Full Text] [Related]

  • 15. Silicone oil as a delivery vehicle for BCNU in rabbit proliferative vitreoretinopathy.
    Arroyo MH, Refojo MF, Araiz JJ, Tolentino FI, Cajita VN, Elner VM.
    Retina; 1993 Jun; 13(3):245-50. PubMed ID: 8235109
    [Abstract] [Full Text] [Related]

  • 16. Effect of adriamycin on experimental proliferative vitreoretinopathy in the rabbit.
    Sunalp MA, Wiedemann P, Sorgente N, Ryan SJ.
    Exp Eye Res; 1985 Jul; 41(1):105-15. PubMed ID: 4029281
    [Abstract] [Full Text] [Related]

  • 17. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.
    Stern WH, Lewis GP, Erickson PA, Guerin CJ, Anderson DH, Fisher SK, O'Donnell JJ.
    Am J Ophthalmol; 1983 Jul; 96(1):33-42. PubMed ID: 6869478
    [Abstract] [Full Text] [Related]

  • 18. Quantitative assessment of growth stimulating activity of the vitreous during PVR.
    Yang CM, Cousins SW.
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2436-42. PubMed ID: 1634341
    [Abstract] [Full Text] [Related]

  • 19. Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy.
    Kirmani M, Santana M, Sorgente N, Wiedemann P, Ryan SJ.
    Retina; 1983 Jul; 3(4):269-72. PubMed ID: 6201971
    [Abstract] [Full Text] [Related]

  • 20. Intraocular injection of silicone oil for experimental proliferative vitreoretinopathy.
    Fastenberg DM, Diddie KR, Delmage JM, Dorey K.
    Am J Ophthalmol; 1983 May; 95(5):663-7. PubMed ID: 6846457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.